+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Biological Valve Market - Global Forecast 2026-2032- Product Image
Artificial Biological Valve Market - Global Forecast 2026-2032- Product Image
New

Artificial Biological Valve Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 197 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6116933
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The artificial biological valve market is evolving rapidly as healthcare organizations prioritize clinical performance, operational resilience, and technology-driven therapies. Senior decision-makers must navigate shifting care models and regulatory frameworks to achieve competitive advantage in cardiovascular innovations.

Market Snapshot: Artificial Biological Valve Market Growth Outlook

The artificial biological valve market advanced from USD 8.30 billion in 2025 to USD 8.72 billion in 2026, with continued expansion anticipated at a CAGR of 5.32%, forecasting a value of USD 11.93 billion by 2032. Growth is propelled by increasing clinical need, a larger aging population, and rising demand for minimally invasive treatments within cardiovascular care. Ongoing product improvements, wider adoption of transcatheter therapies, and new approaches in procurement have influenced competitive strategies and market dynamics.

Scope & Segmentation of the Artificial Biological Valve Market

This analysis offers a clear view of the global artificial biological valve market’s technological, clinical, and commercial landscape. Market segmentation captures the full spectrum of factors leaders must evaluate to successfully identify growth and investment priorities:

  • Tissue Material: Homograft (such as cryopreserved and decellularized) and xenograft (bovine, porcine) valves require unique processing, storage, and end-to-end supply oversight, resulting in distinct operational needs.
  • Implantation Method: Options range from surgical (open or minimally invasive replacement) to transcatheter (including transaortic, transapical, transfemoral) approaches, shaping both product innovation and clinical decision-making.
  • Valve Position: Coverage includes aortic, mitral, pulmonary, and tricuspid valve locations, each demanding tailored engineering due to anatomical and functional requirements.
  • End User: Key environments span ambulatory surgery centers, hospitals, and specialty clinics, with each setting influencing device adoption and workflow integration.
  • Regions: Insights span the Americas, Europe Middle East & Africa, and Asia-Pacific. Each region presents unique regulatory landscapes, trends in clinical adoption, and distinct manufacturing considerations.
  • Technologies: Includes decellularization processes, advanced tissue scaffolds, modular transcatheter valve platforms, imaging tools for procedure planning, and digital supply chain management capabilities.

Key Takeaways for Strategic Decision-Makers

  • Tissue engineering and improvements in delivery technologies are elevating standards for valve performance and procedural simplicity in the artificial biological valve market.
  • Hybrid heart teams and multidisciplinary facilities increasingly guide therapeutic decisions, promoting care models that support individual patient needs and workflow efficiency.
  • Regulatory bodies are focusing on long-term results, encouraging manufacturers to enhance data capture and post-market studies.
  • Procedural efficiency, device compatibility, and integration with existing institutional workflows are shaping clinician adoption and influencing purchasing behaviors.
  • Supply chain management, intellectual property strategies related to tissue processing, and development of value-added services support commercial differentiation.
  • Use of digital health tools—such as advanced procedural planning and patient monitoring platforms—enables manufacturers to leverage data for product optimization and improved outcomes.

Tariff Impact: Navigating U.S. Trade Measures and Supply Chain Strategies

United States tariff actions introduced in 2025 have created new challenges in sourcing, cost management, and supply continuity for artificial biological valve manufacturers. These measures are prompting reassessment of supplier networks and a shift toward regional and domestic processing to help control costs. Clinicians and procurement leaders may see changes in material availability by geography, increasing the importance of alternative materials and standardized protocols. Strategic sourcing, robust inventory practices, and transparent cost evaluation are necessary to mitigate risks from these external factors.

Methodology & Data Sources

Insights in this report are drawn from interviews with clinicians, procurement executives, tissue bank leaders, and device developers. Analysis is supplemented by regulatory filings, clinical registries, post-market surveillance, and peer-reviewed research. Findings were validated by expert advisory boards and cross-referencing real-world clinical evidence to ensure practical and actionable guidance.

Why This Report Matters

  • Equips executives to align investment and portfolio strategies with the regulatory and supply realities of the artificial biological valve market.
  • Supports procurement and manufacturing leaders in building robust value chain solutions to address tariff-driven and quality risks.
  • Assists clinical leaders in refining device selection and procedural workflows to achieve consistent, evidence-based outcomes.

Conclusion

Success in the artificial biological valve market requires agile strategies across research, supply chain, and clinical integration. Proactive adaptation to evolving technologies and regulations positions organizations to deliver clinically effective therapies at scale.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Artificial Biological Valve Market, by Tissue Material
8.1. Homograft
8.1.1. Cryopreserved
8.1.2. Decellularized
8.2. Xenograft
8.2.1. Bovine
8.2.2. Porcine
9. Artificial Biological Valve Market, by Implantation Method
9.1. Surgical
9.1.1. Minimally Invasive
9.1.2. Open Replacement
9.2. Transcatheter
9.2.1. Transaortic
9.2.2. Transapical
9.2.3. Transfemoral
10. Artificial Biological Valve Market, by Valve Position
10.1. Aortic
10.2. Mitral
10.3. Pulmonary
10.4. Tricuspid
11. Artificial Biological Valve Market, by End User
11.1. Ambulatory Surgery Centers
11.2. Hospitals
11.3. Specialized Clinics
12. Artificial Biological Valve Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Artificial Biological Valve Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Artificial Biological Valve Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Artificial Biological Valve Market
16. China Artificial Biological Valve Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. Artivion, Inc.
17.7. Boston Scientific Corporation
17.8. Braile Biomédica
17.9. Colibri Heart Valve
17.10. Corcym
17.11. Edwards Lifesciences
17.12. Foldax, Inc.
17.13. Jenavalve Technology, Inc.
17.14. Labcor Laboratórios Ltda
17.15. Lepu Medical Technology Co., Ltd.
17.16. LifeNet Health
17.17. LivaNova PLC
17.18. Medtronic plc
17.19. TTK Healthcare Limited
List of Figures
FIGURE 1. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY CRYOPRESERVED, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY CRYOPRESERVED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY CRYOPRESERVED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY DECELLULARIZED, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY DECELLULARIZED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY DECELLULARIZED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY BOVINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY BOVINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY BOVINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY PORCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY PORCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY PORCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY OPEN REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY OPEN REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY OPEN REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSAORTIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSAORTIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSAORTIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSAPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSAPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSAPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSFEMORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSFEMORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSFEMORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY AORTIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY AORTIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY AORTIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY MITRAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY MITRAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY MITRAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY PULMONARY, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY PULMONARY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY PULMONARY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRICUSPID, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRICUSPID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRICUSPID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SPECIALIZED CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SPECIALIZED CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 72. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2032 (USD MILLION)
TABLE 94. LATIN AMERICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
TABLE 97. LATIN AMERICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2032 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2032 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2032 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2032 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. EUROPE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. EUROPE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2032 (USD MILLION)
TABLE 109. EUROPE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2032 (USD MILLION)
TABLE 110. EUROPE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2032 (USD MILLION)
TABLE 111. EUROPE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2032 (USD MILLION)
TABLE 112. EUROPE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 113. EUROPE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 114. EUROPE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
TABLE 115. EUROPE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2032 (USD MILLION)
TABLE 121. MIDDLE EAST ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 122. MIDDLE EAST ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 123. MIDDLE EAST ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
TABLE 124. MIDDLE EAST ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2032 (USD MILLION)
TABLE 127. AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2032 (USD MILLION)
TABLE 128. AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2032 (USD MILLION)
TABLE 129. AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2032 (USD MILLION)
TABLE 130. AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 131. AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 132. AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
TABLE 133. AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 144. ASEAN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. ASEAN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2032 (USD MILLION)
TABLE 146. ASEAN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2032 (USD MILLION)
TABLE 147. ASEAN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2032 (USD MILLION)
TABLE 148. ASEAN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2032 (USD MILLION)
TABLE 149. ASEAN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 150. ASEAN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 151. ASEAN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
TABLE 152. ASEAN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 153. GCC ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. GCC ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2032 (USD MILLION)
TABLE 155. GCC ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2032 (USD MILLION)
TABLE 156. GCC ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2032 (USD MILLION)
TABLE 157. GCC ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2032 (USD MILLION)
TABLE 158. GCC ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 159. GCC ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 160. GCC ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
TABLE 161. GCC ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 162. EUROPEAN UNION ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. EUROPEAN UNION ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2032 (USD MILLION)
TABLE 164. EUROPEAN UNION ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2032 (USD MILLION)
TABLE 165. EUROPEAN UNION ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2032 (USD MILLION)
TABLE 167. EUROPEAN UNION ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 168. EUROPEAN UNION ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 169. EUROPEAN UNION ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
TABLE 170. EUROPEAN UNION ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. BRICS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. BRICS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2032 (USD MILLION)
TABLE 173. BRICS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2032 (USD MILLION)
TABLE 174. BRICS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2032 (USD MILLION)
TABLE 175. BRICS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2032 (USD MILLION)
TABLE 176. BRICS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 177. BRICS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 178. BRICS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
TABLE 179. BRICS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. G7 ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. G7 ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2032 (USD MILLION)
TABLE 182. G7 ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2032 (USD MILLION)
TABLE 183. G7 ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2032 (USD MILLION)
TABLE 184. G7 ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2032 (USD MILLION)
TABLE 185. G7 ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 186. G7 ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 187. G7 ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
TABLE 188. G7 ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. NATO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. NATO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2032 (USD MILLION)
TABLE 191. NATO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2032 (USD MILLION)
TABLE 192. NATO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2032 (USD MILLION)
TABLE 193. NATO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2032 (USD MILLION)
TABLE 194. NATO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 195. NATO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 196. NATO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
TABLE 197. NATO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 200. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2032 (USD MILLION)
TABLE 201. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2032 (USD MILLION)
TABLE 202. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2032 (USD MILLION)
TABLE 203. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2032 (USD MILLION)
TABLE 204. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 205. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 206. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
TABLE 207. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 208. CHINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 209. CHINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2032 (USD MILLION)
TABLE 210. CHINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2032 (USD MILLION)
TABLE 211. CHINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2032 (USD MILLION)
TABLE 212. CHINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2032 (USD MILLION)
TABLE 213. CHINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 214. CHINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 215. CHINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
TABLE 216. CHINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

  • Abbott Laboratories
  • Artivion, Inc.
  • Boston Scientific Corporation
  • Braile Biomédica
  • Colibri Heart Valve
  • Corcym
  • Edwards Lifesciences
  • Foldax, Inc.
  • Jenavalve Technology, Inc.
  • Labcor Laboratórios Ltda
  • Lepu Medical Technology Co., Ltd.
  • LifeNet Health
  • LivaNova PLC
  • Medtronic plc
  • TTK Healthcare Limited

Table Information

Report AttributeDetails
No. of Pages197
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 8.72 Billion
Forecasted Market Value ( USD ) by 2032 $ 11.93 Billion
Compound Annual Growth Rate5.3%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Valves Market 2025-2029 - Product Image

Valves Market 2025-2029

  • Report
  • 238 Pages
  • Global
From
United States Valves - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

United States Valves - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 120 Pages
  • United States
From
North America Valves - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

North America Valves - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 100 Pages
  • North America
From
Commercial Vehicle AC Valves Market - Global Strategic Business Report - Product Image

Commercial Vehicle AC Valves Market - Global Strategic Business Report

  • Report
  • 365 Pages
  • Global
From
Artificial Pulmonary Valve System Market - Global Forecast 2026-2032 - Product Image

Artificial Pulmonary Valve System Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.